• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSTITUT STRAUMANN AG BL, Ø 3.3 MM, NC, SLACTIVE 10 MM, TIZR; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSTITUT STRAUMANN AG BL, Ø 3.3 MM, NC, SLACTIVE 10 MM, TIZR; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number 021.2210
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Codes Hypersensitivity/Allergic reaction (1907); Pain (1994)
Date of Event 02/24/2026
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2010 in ada 15.Details of surgery: sinus augmentation.On (b)(6) 2026, fracture of the implant was verified.Patient presented with bone type iii.The device was forwarded to the manufacturer.At the event the patient experienced: pain and hypersensitivity.No further patient complications were reported.
 
Additional Manufacturer Narrative
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.The fracture of a dental implant is a known long-term complication of endosseous dental implants.The manufacturers trend analysis confirms that the reported implant fracture rate associated with its dental implants is low and remains consistent with the experience as documented in the literature.There are different reasons why implants break and this problem has been illuminated by various authors (e.G.Maeglin 1988, beumer 1989, tetsch 1991, worthington 1992).Beumer and lewis 1989 report the following causes: a) production / design flaws.B) inadequate fitting of the suprastructure.C) occlusal overload.D) bruxism.E) bone resorption around the implants.F) insufficient axle alignment of the implants.G) trauma.H) biomechanical causes.I) design of the suprastructure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BL, Ø 3.3 MM, NC, SLACTIVE 10 MM, TIZR
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
INSTITUT STRAUMANN AG
peter merian-weg 12
basel 04002
SZ  04002
Manufacturer (Section G)
INSTITUT STRAUMANN AG
peter merian-weg 12
basel 04002
SZ   04002
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
9787472509
MDR Report Key24675970
Report Number0009613348-2026-004332
Device Sequence Number16006152
Product Code DZE
UDI-Device Identifier07630031706409
UDI-Public07630031706409
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K083550
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 03/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/31/2015
Device Catalogue Number021.2210
Device Lot NumberZ3825
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/25/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/24/2026
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/31/2010
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age53 YR
Patient SexMale
-
-